Effects of vascular endothelial growth factor B on proliferation and migration in EA.Hy926 cells

Molecular Biology Reports

Volumn 41, Issue 2, 2014, Pages 779-785

  Zhang, Guang Hong ^a   Qin, Rui ^b   Zhang, Shui Hua ^c   Zhu, He ^c  

^a No 474 Hospital of Chinese PLA   (China)

^b The People's Hospital of Bozhou   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Migration; Phosphorylation; Proliferation; VEGF B

Indexed keywords

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; OPTIC NERVE; PHOSPHORYLATION; RETINAL GANGLION CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR B;

EID: 84899438264     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2917-4     Document Type: Article

References (38)

1. Silvestre JS, Tamarat R, Ebrahimian TG et al (2003) Vascular endothelial growth factor-b promotes in vivo angiogenesis. Circ Res 93:114-123 (Pubitemid 36919698)
2. Clauss M (2000) Molecular biology of the EGF and the VEGF receptor family. Semin Thromb Hemost 26(5):561-569
3. Ferrara N, Gerber HP, LeCouter J et al (2003) The biology of VEGF and its receptors. Nat Med 9(6):669-676 (Pubitemid 36749215)
4. Li X (2001) Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D. Int J Biochem Cell Biol 33:421-426
5. Holmes DI, Zachary I et al (2005) The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Gonome Biol 6:209
6. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P (2009) Role and therapeutic potential of VEGF in the nervous system. Phys Rev 89:607-648
7. Witmer AN, Blaauwgeers HG, Weich HA et al (2002) Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF induced VEGF induced retinopathy in monkey. Invest Ophthalmol Vis Sci 43:849-857 (Pubitemid 34184506)
8. Ogawa S, Oku A, Sawano A et al (1998) A novel type of vascular endothelial growth factor, VEGFE (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. Biol Chem 273:31273-31282 (Pubitemid 28533143)
9. Meyer M, Clauss M, Lepple-Wienhues A et al (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGFE, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 15:363-374 (Pubitemid 29041945)
10. Joukov V, Pajusola K, Kaipainen A et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298 (Pubitemid 26029207)
11. Ferrara N, Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5:1359-1364
12. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
13. Nash AD, Baca M, Wright C, Scotney PD (2006) The biology of vascular endothelial growth factor-B (VEGF-B). Pulm Pharmacol Ther 19:61-69 (Pubitemid 41606854)
14. Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220 (Pubitemid 29273837)
15. Li X (2012) Complicated life, complicated VEGF-B. Trends Mol Med 18:119-127
16. Li X (2010) VEGF-B: a thing of beauty. Cell Res 20:741-744
17. Li X (2009) VEGF-B: a survival, or an angiogenic factor? Cell Adh Migr 3:322-327
18. Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25 (Pubitemid 27076453)
19. Li X (2001) Isoform-specific expression of VEGF-B in normal tissues and tumors. Growth Factors 19:49-59
20. Kanno S, Oda N, Abe M, et al (2000) Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF e.ects in human vascular endothelial cells. Oncogene 19:2138-2146 (Pubitemid 30251379)
21. Wright CE (2002) Effects of vascular endothelial growth factor (VEGF)A and VEGFB gene transfer on vascular reserve in a conscious rabbit hindlimb ischaemia model. Clin Exp Pharmacol Physiol 29:1035-1039
22. Mould AW, Greco SA, Cahill MM et al (2005) Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro. Circ Res 97:e60-e70
23. Yoon YS, Losordo DW (2003) All in the family: VEGF-B joins the ranks of proangiogenic cytokines. Circ Res 93:87-90
24. Li X et al (2008) Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol 28:1614-1620
25. Zhang F (2009) VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci USA 106:6152-6157
26. Malik AK, Baldwin ME, Peale F et al (2006) Redundant roles of VEGFB and PlGF during selective VEGF-A blockade in mice. Blood 107:550-557 (Pubitemid 43076378)
27. Aase K, von Euler G, Li X et al (2003) Vascular endothelial growth factor-B and retinal vascular development in the mouse. Clin Exp Ophthalmol 31:61-65
28. Rissanen TT, Markkanen JE, Gruchala M et al (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92:1098-1106 (Pubitemid 36665855)
29. Bhardwaj S, Roy H, Gruchala M et al (2003) Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum Gene Ther 14:1451-1462 (Pubitemid 37268223)
30. Van de Veire S, Stalmans I, Heindryckx F et al (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141:178-190
31. Zhang XF, Huang H, Shen JK et al (2011) Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis 17:492-507
32. Zhang SH, Qu Y (2009) Effect of VEGF-B on neuroprotection in mouse retinal ganglion cells. Chin J Ophthalmol 45(1):38-42
33. Li Y et al (2008) VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 118:913-923 (Pubitemid 351364599)
34. Edgell C, McDonald C, Graham J (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80(12):3734
35. Persico MG, Vincenti V, DiPalma T (1999) Structure, expression and receptorbinding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 237:31-40 (Pubitemid 128767693)
36. Makinen T, Olofsson B, Karpanen T et al (1999) Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 274:21217-21222
37. Conway EM, Carmeliet P (2004) The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol 5:207
38. Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158-173